{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_omalizumab",
          "name": "Omalizumab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_brodalumab",
          "name": "Brodalumab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_tildrakizumab",
          "name": "Tildrakizumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_guselkumab",
          "name": "Guselkumab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_acitretin",
          "type": "Target",
          "label": "OffTarget_Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_acitretin",
          "type": "Pathway",
          "label": "RiskPathway_Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_acitretin",
          "type": "Phenotype",
          "label": "AdversePhenotype_Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_adalimumab",
          "type": "Target",
          "label": "OffTarget_Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_adalimumab",
          "type": "Pathway",
          "label": "RiskPathway_Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_adalimumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_etanercept",
          "type": "Target",
          "label": "OffTarget_Etanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_etanercept",
          "type": "Pathway",
          "label": "RiskPathway_Etanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_etanercept",
          "type": "Phenotype",
          "label": "AdversePhenotype_Etanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_infliximab",
          "type": "Target",
          "label": "OffTarget_Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_infliximab",
          "type": "Pathway",
          "label": "RiskPathway_Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_infliximab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_methotrexate",
          "type": "Target",
          "label": "OffTarget_Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_methotrexate",
          "type": "Pathway",
          "label": "RiskPathway_Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_methotrexate",
          "type": "Phenotype",
          "label": "AdversePhenotype_Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_omalizumab",
          "type": "Target",
          "label": "OffTarget_Omalizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_omalizumab",
          "type": "Pathway",
          "label": "RiskPathway_Omalizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_omalizumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Omalizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_secukinumab",
          "type": "Target",
          "label": "OffTarget_Secukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_secukinumab",
          "type": "Pathway",
          "label": "RiskPathway_Secukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_secukinumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Secukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ustekinumab",
          "type": "Target",
          "label": "OffTarget_Ustekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ustekinumab",
          "type": "Pathway",
          "label": "RiskPathway_Ustekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ustekinumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Ustekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_brodalumab",
          "type": "Target",
          "label": "OffTarget_Brodalumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_brodalumab",
          "type": "Pathway",
          "label": "RiskPathway_Brodalumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_brodalumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Brodalumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_apremilast",
          "type": "Target",
          "label": "OffTarget_Apremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_apremilast",
          "type": "Pathway",
          "label": "RiskPathway_Apremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_apremilast",
          "type": "Phenotype",
          "label": "AdversePhenotype_Apremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_tildrakizumab",
          "type": "Target",
          "label": "OffTarget_Tildrakizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_tildrakizumab",
          "type": "Pathway",
          "label": "RiskPathway_Tildrakizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_tildrakizumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Tildrakizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_guselkumab",
          "type": "Target",
          "label": "OffTarget_Guselkumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_guselkumab",
          "type": "Pathway",
          "label": "RiskPathway_Guselkumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_guselkumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Guselkumab",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_acitretin",
          "target": "n_ot_acitretin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的离靶作用"
        },
        {
          "source": "n_ot_acitretin",
          "target": "n_rp_acitretin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发相关风险通路"
        },
        {
          "source": "n_rp_acitretin",
          "target": "n_adv_acitretin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_acitretin",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消治疗益处"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_ot_adalimumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的离靶作用"
        },
        {
          "source": "n_ot_adalimumab",
          "target": "n_rp_adalimumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发相关风险通路"
        },
        {
          "source": "n_rp_adalimumab",
          "target": "n_adv_adalimumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_adalimumab",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消治疗益处"
        },
        {
          "source": "drug_etanercept",
          "target": "n_ot_etanercept",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的离靶作用"
        },
        {
          "source": "n_ot_etanercept",
          "target": "n_rp_etanercept",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发相关风险通路"
        },
        {
          "source": "n_rp_etanercept",
          "target": "n_adv_etanercept",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_etanercept",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消治疗益处"
        },
        {
          "source": "drug_infliximab",
          "target": "n_ot_infliximab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的离靶作用"
        },
        {
          "source": "n_ot_infliximab",
          "target": "n_rp_infliximab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发相关风险通路"
        },
        {
          "source": "n_rp_infliximab",
          "target": "n_adv_infliximab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_infliximab",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消治疗益处"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ot_methotrexate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的离靶作用"
        },
        {
          "source": "n_ot_methotrexate",
          "target": "n_rp_methotrexate",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发相关风险通路"
        },
        {
          "source": "n_rp_methotrexate",
          "target": "n_adv_methotrexate",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_methotrexate",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消治疗益处"
        },
        {
          "source": "drug_omalizumab",
          "target": "n_ot_omalizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的离靶作用"
        },
        {
          "source": "n_ot_omalizumab",
          "target": "n_rp_omalizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发相关风险通路"
        },
        {
          "source": "n_rp_omalizumab",
          "target": "n_adv_omalizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_omalizumab",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消治疗益处"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_ot_secukinumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的离靶作用"
        },
        {
          "source": "n_ot_secukinumab",
          "target": "n_rp_secukinumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发相关风险通路"
        },
        {
          "source": "n_rp_secukinumab",
          "target": "n_adv_secukinumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_secukinumab",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消治疗益处"
        },
        {
          "source": "drug_ustekinumab",
          "target": "n_ot_ustekinumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的离靶作用"
        },
        {
          "source": "n_ot_ustekinumab",
          "target": "n_rp_ustekinumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发相关风险通路"
        },
        {
          "source": "n_rp_ustekinumab",
          "target": "n_adv_ustekinumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_ustekinumab",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消治疗益处"
        },
        {
          "source": "drug_brodalumab",
          "target": "n_ot_brodalumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的离靶作用"
        },
        {
          "source": "n_ot_brodalumab",
          "target": "n_rp_brodalumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发相关风险通路"
        },
        {
          "source": "n_rp_brodalumab",
          "target": "n_adv_brodalumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_brodalumab",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消治疗益处"
        },
        {
          "source": "drug_apremilast",
          "target": "n_ot_apremilast",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的离靶作用"
        },
        {
          "source": "n_ot_apremilast",
          "target": "n_rp_apremilast",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发相关风险通路"
        },
        {
          "source": "n_rp_apremilast",
          "target": "n_adv_apremilast",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_apremilast",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消治疗益处"
        },
        {
          "source": "drug_tildrakizumab",
          "target": "n_ot_tildrakizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的离靶作用"
        },
        {
          "source": "n_ot_tildrakizumab",
          "target": "n_rp_tildrakizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发相关风险通路"
        },
        {
          "source": "n_rp_tildrakizumab",
          "target": "n_adv_tildrakizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_tildrakizumab",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消治疗益处"
        },
        {
          "source": "drug_guselkumab",
          "target": "n_ot_guselkumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的离靶作用"
        },
        {
          "source": "n_ot_guselkumab",
          "target": "n_rp_guselkumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发相关风险通路"
        },
        {
          "source": "n_rp_guselkumab",
          "target": "n_adv_guselkumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_guselkumab",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消治疗益处"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": []
    },
    "counterclaims": [],
    "assumptions_challenged": [],
    "falsification_tests": [],
    "next_focus_for_pi": []
  }
}